SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Doctor Falsely Prescribes Drugs to Give Students an "Edge"
Stimulants help "even the scales" for low-income students
Oct 09, 2012
Dr. Michael Anderson, a Georgian pediatrician, considers prescription medicine the next great equalizer. The New York Times reports on the practice of prescribing stimulants to under-performing, low-income students to help them get an edge in schools.
Anderson, "one of the more outspoken proponents" of this idea, admits to falsely diagnosing children with attention deficit and hyperactivity disorder (ADHD) in order to prescribe medication--namely the drug Adderall--to treat the 'true' ailment: "poor academic performance in inadequate schools."
"I don't have a whole lot of choice," said Dr. Anderson, a pediatrician for many poor families in Cherokee County, north of Atlanta. "We've decided as a society that it's too expensive to modify the kid's environment. So we have to modify the kid."
Adderall's intended use is to boost focus and impulse control in people suffering with ADHD. Reported side effects include growth suppression, increased blood pressure and--in rare cases--psychotic episodes; they are classified by the DEA as Schedule II Controlled Substances because they are particularly addictive.
The article points out that it is not uncommon among wealthy college and high school students to abuse stimulants in order to perform better in school. It appears that the trend may be spreading to low-income families whose young children are not performing well in schools that are often underfunded and over-crowded. Anderson believes that he is "evening the scales a bit" for children whose families can't afford behavior-based therapies "like tutoring and family counseling."
Dr. Nancy Rappaport, a child psychiatrist in Cambridge, Mass., who works primarily with lower-income children and their schools, told the New York Times: "We are seeing this more and more. We are using a chemical straitjacket instead of doing things that are just as important to also do, sometimes more."
The superintendent of a major California school district--who spoke to the NY Times on the condition of anonymity--noted that diagnosis rates of ADHD have risen as sharply as school funding has declined. ADHD is an increasingly common diagnosis. The Centers for Disease Control and Prevention reports that rates of ADHD diagnosis increased an average of 3% per year from 1997 to 2006 and an average of 5.5% per year from 2003 to 2007, amounting to 5.4 million children age 4-7 diagnosed as of 2007.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Dr. Michael Anderson, a Georgian pediatrician, considers prescription medicine the next great equalizer. The New York Times reports on the practice of prescribing stimulants to under-performing, low-income students to help them get an edge in schools.
Anderson, "one of the more outspoken proponents" of this idea, admits to falsely diagnosing children with attention deficit and hyperactivity disorder (ADHD) in order to prescribe medication--namely the drug Adderall--to treat the 'true' ailment: "poor academic performance in inadequate schools."
"I don't have a whole lot of choice," said Dr. Anderson, a pediatrician for many poor families in Cherokee County, north of Atlanta. "We've decided as a society that it's too expensive to modify the kid's environment. So we have to modify the kid."
Adderall's intended use is to boost focus and impulse control in people suffering with ADHD. Reported side effects include growth suppression, increased blood pressure and--in rare cases--psychotic episodes; they are classified by the DEA as Schedule II Controlled Substances because they are particularly addictive.
The article points out that it is not uncommon among wealthy college and high school students to abuse stimulants in order to perform better in school. It appears that the trend may be spreading to low-income families whose young children are not performing well in schools that are often underfunded and over-crowded. Anderson believes that he is "evening the scales a bit" for children whose families can't afford behavior-based therapies "like tutoring and family counseling."
Dr. Nancy Rappaport, a child psychiatrist in Cambridge, Mass., who works primarily with lower-income children and their schools, told the New York Times: "We are seeing this more and more. We are using a chemical straitjacket instead of doing things that are just as important to also do, sometimes more."
The superintendent of a major California school district--who spoke to the NY Times on the condition of anonymity--noted that diagnosis rates of ADHD have risen as sharply as school funding has declined. ADHD is an increasingly common diagnosis. The Centers for Disease Control and Prevention reports that rates of ADHD diagnosis increased an average of 3% per year from 1997 to 2006 and an average of 5.5% per year from 2003 to 2007, amounting to 5.4 million children age 4-7 diagnosed as of 2007.
Dr. Michael Anderson, a Georgian pediatrician, considers prescription medicine the next great equalizer. The New York Times reports on the practice of prescribing stimulants to under-performing, low-income students to help them get an edge in schools.
Anderson, "one of the more outspoken proponents" of this idea, admits to falsely diagnosing children with attention deficit and hyperactivity disorder (ADHD) in order to prescribe medication--namely the drug Adderall--to treat the 'true' ailment: "poor academic performance in inadequate schools."
"I don't have a whole lot of choice," said Dr. Anderson, a pediatrician for many poor families in Cherokee County, north of Atlanta. "We've decided as a society that it's too expensive to modify the kid's environment. So we have to modify the kid."
Adderall's intended use is to boost focus and impulse control in people suffering with ADHD. Reported side effects include growth suppression, increased blood pressure and--in rare cases--psychotic episodes; they are classified by the DEA as Schedule II Controlled Substances because they are particularly addictive.
The article points out that it is not uncommon among wealthy college and high school students to abuse stimulants in order to perform better in school. It appears that the trend may be spreading to low-income families whose young children are not performing well in schools that are often underfunded and over-crowded. Anderson believes that he is "evening the scales a bit" for children whose families can't afford behavior-based therapies "like tutoring and family counseling."
Dr. Nancy Rappaport, a child psychiatrist in Cambridge, Mass., who works primarily with lower-income children and their schools, told the New York Times: "We are seeing this more and more. We are using a chemical straitjacket instead of doing things that are just as important to also do, sometimes more."
The superintendent of a major California school district--who spoke to the NY Times on the condition of anonymity--noted that diagnosis rates of ADHD have risen as sharply as school funding has declined. ADHD is an increasingly common diagnosis. The Centers for Disease Control and Prevention reports that rates of ADHD diagnosis increased an average of 3% per year from 1997 to 2006 and an average of 5.5% per year from 2003 to 2007, amounting to 5.4 million children age 4-7 diagnosed as of 2007.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.
To inform. To inspire. To ignite change for the common good.
News & Opinion
Trending
Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit
Privacy Policy